股息配發率   玩股撇步(動畫小學堂)

  • 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
  • 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
  • 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY現金股利 YoY股票股利 YoY現金配發率 YoY股票配發率 YoY全部配發率 YoY
2025 (5)-1.9600.0000.0000.0000.0000.000
2024 (4)-1.7100.0000.0000.0000.0000.000
2023 (3)4.4900.0000.0000.0000.0000.000
每股盈餘-近8季
EPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY
26Q1 (8)-0.392.5-14.71-0.507.41-51.52-0.3980.1-14.71
25Q4 (7)-0.4020.0-350.0-0.540.028.0-1.96-25.64-14.62
25Q3 (6)-0.5031.5112.28-0.540.00.0-1.56-47.1716.58
25Q2 (5)-0.73-114.71-43.14-0.54-63.640.0-1.06-211.7618.46
25Q1 (4)-0.34-312.50.0-0.3356.00.0-0.3480.120.0
24Q4 (3)0.16128.070.0-0.75-38.890.0-1.718.560.0
24Q3 (2)-0.57-11.760.0-0.540.00.0-1.87-43.850.0
24Q2 (1)-0.510.00.0-0.540.00.0-1.300.00.0
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2026/40.08-35.2-38.530.49-39.290.33N/A-
2026/30.1310.05-65.590.4-39.450.41.09因動物醫療儀器較去年減少所致。
2026/20.12-22.28-14.520.27-4.560.510.86-
2026/10.15-35.994.950.154.950.540.82-
2025/120.2464.0697.372.04-15.010.540.84本公司動物醫療儀器出貨量較去年同期增加。
2025/110.15-5.2-1.071.8-20.960.490.93-
2025/100.15-17.92-49.481.66-22.330.490.92-
2025/90.1924.3121.471.5-17.830.461.2-
2025/80.1524.44-40.131.32-21.440.361.54-
2025/70.1242.14-37.281.17-18.140.371.51-
2025/60.09-46.65-55.071.05-15.150.381.41本公司動物醫療儀器出貨量較去年同期減少,收入下降
2025/50.1615.73-12.450.96-7.920.680.8-
2025/40.14-63.73-19.360.8-6.960.660.82-
2025/30.38173.4444.490.66-3.90.660.72-
2025/20.14-4.57-52.890.28-43.350.451.06喪失睿邑公司控制力,不將該公司營收併入集團營收。
2025/10.15-12.64-29.80.15-29.80.471.02-
2024/120.175.24-46.133.0812.270.630.75-
2024/110.16-47.88-22.312.9219.680.720.65-
2024/100.318.11-21.042.7623.510.890.53-
2024/90.26-20.65-34.012.4632.780.831.01-
2024/80.3230.5145.832.250.620.880.95主係保健食品銷量增加
2024/70.25-19.3641.541.8751.480.771.09主係保健食品銷量增加
2024/60.3145.27183.651.6353.120.811.05主係保健食品銷量增加
2024/50.21-26.1616.381.3238.250.821.04-
2024/40.29-9.350.981.1143.410.90.95主係保健食品銷量增加
2024/30.327.3827.920.8240.940.82N/A-
2024/20.2942.270.860.550.590.81N/A主係保健食品銷量增加
2024/10.21-32.9728.860.2128.860.72N/A-
2023/120.3151.847.642.817.40.97N/A-
2023/110.2-54.99-4.272.513.91.05N/A-
2023/100.4516.15199.312.34.691.06N/A本公司新增保健食品業務,整體收入較同期上升
2023/90.3975.3654.311.85-9.670.79N/A本公司新增保健食品業務,整體收入較同期上升
2023/80.2226.68-2.811.46-18.680.51N/A-
2023/70.1861.58-40.541.24-21.00.47N/A-
2023/60.11-40.38-64.891.06-16.460.48N/A本公司機台出貨量較去年同期減少,收入下降
2023/50.18-4.21-30.030.95-0.890.62N/A-
2023/40.19-23.1535.050.779.910.61N/A-
2023/30.2543.4316.870.583.60.58N/A-
2023/20.177.2411.710.33-4.440.54N/A-
2023/10.16-23.2-17.280.16-17.280.58N/A-
2022/120.21-1.5776.422.62114.230.57N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/110.2140.7280.022.41118.30.62N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/100.15-40.1191.772.2122.890.63N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/90.2510.44108.912.05125.590.78N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/80.23-22.5209.851.79128.160.83N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/70.3-4.58277.551.57119.690.86N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/60.3118.879.01.27100.260.71N/A本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/50.2684.89214.680.96108.210.61N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/40.14-33.596.930.784.980.51N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/30.2137.09171.030.5682.210.56N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/20.15-20.5847.610.3551.990.47N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/10.1963.7855.650.1955.650.43N/A本公司新增動物醫療儀器設備產品,整體收入較同期上升
2021/120.120.43-19.61.2220.510.32N/A-
2021/110.1249.9174.691.127.340.32N/A本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/100.08-34.7523.650.9919.650.27N/A-
2021/90.1263.8131.190.9119.310.27N/A本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/80.07-5.56-40.730.7911.050.32N/A-
2021/70.08-54.76-25.180.7122.110.33N/A-
2021/60.17108.84169.010.6332.410.0N/A係受新冠疫情影響,本公司防疫產品銷量增加。
2021/50.0815.7-16.750.4611.280.0N/A-

股利相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。